INTEGRA LIFESCIENCES HOLDINGS CORP Repayments of Convertible Debt
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Repayments of Convertible Debt of $574.98 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2026-02-26
- INTEGRA LIFESCIENCES HOLDINGS CORP repayments of convertible debt for the quarter ending 2025-12-31 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP repayments of convertible debt for the quarter ending 2024-12-31 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP repayments of convertible debt for the quarter ending 2016-12-31 was $184.31M.
- INTEGRA LIFESCIENCES HOLDINGS CORP repayments of convertible debt for the quarter ending 2015-12-31 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP repayments of convertible debt for fiscal 2025 was $574.98M.
- INTEGRA LIFESCIENCES HOLDINGS CORP repayments of convertible debt for fiscal 2024 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP repayments of convertible debt for fiscal 2023 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP repayments of convertible debt for fiscal 2018 was $0.00.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $574.98M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $574.98M 10-Q · filed 2025-10-30 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-10-30 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2018-12-31 | $0.00 10-K · filed 2019-02-26 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-02-26 | |||
| 2016-12-31 | $184.31M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $184.31M 10-K · filed 2019-02-26 | ||
| 2016-09-30 | $0.00 10-Q · filed 2016-10-28 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $2.52M 10-K · filed 2018-03-01 | ||
| 2015-09-30 | $2.52M 10-Q · filed 2016-10-28 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-23 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $0.00 derived: sum of 2 quarters · filed 2016-02-26 | $0.00 10-K · filed 2016-02-26 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-10-30 | $0.00 10-Q · filed 2013-10-30 | ||
| 2013-06-30 | $0.00 10-Q/A · filed 2013-08-02 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $0.00 derived: sum of 2 quarters · filed 2015-02-27 | $134.38M 10-K · filed 2015-02-27 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-10-30 | $134.38M 10-Q · filed 2013-10-30 | ||
| 2012-06-30 | $134.38M 10-Q/A · filed 2013-08-02 | |||
| 2011-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $0.00 8-K · filed 2014-06-20 | ||
| 2011-09-30 | $0.00 10-Q · filed 2012-10-24 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $0.00 derived: sum of 2 quarters · filed 2013-02-26 | $71.35M 10-K · filed 2013-02-26 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $71.35M 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | $71.35M 10-Q · filed 2011-08-01 | |||
| 2009-12-31 | $17.13M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $33.19M derived: sum of 2 quarters · filed 2012-02-27 | $78.00M 10-K · filed 2012-02-27 | |
| 2009-09-30 | $16.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $60.88M 10-Q · filed 2010-10-28 | ||
| 2009-06-30 | $44.82M 10-Q · filed 2010-07-29 | |||
| 2008-12-31 | $119.56M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |